ZNF185 is a p53 target gene following DNA damage

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• The tumor suppressor p53 is crucial for DNA damage response, regulating target genes involved in cell cycle control.
• p53's role in cell motility and metastasis, particularly concerning directional cell movement, remains largely unexplored.
• Actin cytoskeleton dynamics are essential for cell shape, motility, and polarization, processes often dysregulated in cancer.

Purpose of the Study:

• To investigate the role of ZNF185, an actin cytoskeleton-associated protein, in the p53-mediated response to DNA damage.
• To determine if ZNF185 is a direct target gene of p53.
• To explore the functional consequences of ZNF185 modulation on cellular processes and its potential as a cancer biomarker.

Main Methods:

• Chromatin immunoprecipitation sequencing (ChIP-seq) and luciferase assays to identify p53 target genes.
• Genotoxic stress induction using etoposide and UVB irradiation.
• ZNF185 depletion experiments to assess effects on cell proliferation, apoptosis, actin cytoskeleton remodeling, and cell polarization.
• Bioinformatic analysis of TCGA and GTEx databases for ZNF185 mRNA levels in cancer versus normal tissues.
• Tissue microarray immunohistochemistry (IHC) staining for ZNF185 protein levels.

Main Results:

• ZNF185 is identified as a direct p53 target gene, with its expression upregulated upon genotoxic stress.
• ZNF185 depletion in etoposide-treated cells did not affect proliferation or apoptosis but impaired actin cytoskeleton remodeling and cell polarization.
• Bioinformatic analysis revealed significantly decreased ZNF185 mRNA levels in various epithelial cancers compared to normal tissues.
• IHC staining confirmed reduced ZNF185 protein levels in cancerous tissues.

Conclusions:

• ZNF185 is a novel p53 target gene involved in regulating the actin cytoskeleton and cell polarization in response to genotoxic stress.
• The downregulation of ZNF185 in epithelial cancers suggests its involvement in tumorigenesis and metastasis.
• ZNF185 represents a potential diagnostic biomarker for epithelial cancers, warranting further investigation.